Vaxxinity Inc. (VAXX)
OTC: VAXX
· Real-Time Price · USD
0.05
0.02 (99.60%)
At close: Mar 26, 2025, 2:50 PM
Vaxxinity Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | 50K | n/a | 17K |
Cost of Revenue | 456K | 666K | 512K | n/a | 540K | n/a | 392K | 333K | 174K | 9K | 1.93M | 1K |
Gross Profit | -456K | -666K | -512K | n/a | -540K | n/a | -392K | -333K | -175K | 41K | -1.93M | 16K |
Operating Income | -11.65M | -13.45M | -14.43M | -18.81M | -20.82M | -19.77M | -17.22M | -18.16M | -47.85M | -30.27M | -26.8M | -20.26M |
Interest Income | 433K | 512K | 578K | 567K | 634K | 545K | 75K | 5K | n/a | 3K | 2K | n/a |
Pretax Income | -11.39M | -13.14M | -13.98M | -18.42M | -20.46M | -19.25M | -17.25M | -18.26M | -48.19M | -30.39M | -26.91M | -32.02M |
Net Income | -11.39M | -13.14M | -13.98M | -18.42M | -20.47M | -19.25M | -17.28M | -18.26M | -48.19M | -30.39M | -26.91M | -32.02M |
Selling & General & Admin | 3.43M | 5.54M | 6.08M | 7.38M | 7.81M | 7.3M | 6.56M | 6.69M | 30.7M | 6.7M | 5.92M | 8.58M |
Research & Development | 7.76M | 7.91M | 8.35M | 11.42M | 13.02M | 12.47M | 10.66M | 11.48M | 17.16M | 23.62M | 18.94M | 11.69M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.67M | n/a | n/a | -2.67M |
Operating Expenses | 11.19M | 13.45M | 14.43M | 18.81M | 20.82M | 19.77M | 17.22M | 18.16M | 47.85M | 30.32M | 24.87M | 20.27M |
Interest Expense | 182K | 176K | 146K | 192K | 250K | 54K | 105K | 105K | 347K | 109K | 107K | 511K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.65M | 13.45M | 14.43M | 18.81M | 20.82M | 19.77M | 17.22M | 18.16M | 47.85M | 30.32M | 26.8M | 20.27M |
Income Tax Expense | n/a | 176K | 146K | n/a | 16K | 54K | 28K | -1K | 3.01M | 109K | 107K | -2.16M |
Shares Outstanding (Basic) | 127.22M | 126.74M | 126.48M | 126.06M | 126.06M | 126.04M | 125.95M | 125.71M | 125.39M | 125.39M | 124.75M | 124.75M |
Shares Outstanding (Diluted) | 127.22M | 126.74M | 126.48M | 126.06M | 126.06M | 126.04M | 125.95M | 125.71M | 125.39M | 125.45M | 124.75M | 124.75M |
EPS (Basic) | -0.09 | -0.1 | -0.11 | -0.15 | -0.16 | -0.15 | -0.14 | -0.15 | -0.38 | -0.24 | -0.22 | -0.26 |
EPS (Diluted) | -0.09 | -0.1 | -0.11 | -0.15 | -0.16 | -0.15 | -0.14 | -0.15 | -0.38 | -0.24 | -0.22 | -0.26 |
EBITDA | -11.19M | -12.78M | -13.3M | -17.64M | -20.28M | -19.35M | -16.83M | -17.82M | -47.68M | -29.91M | -26.52M | -22.64M |
EBIT | -11.21M | -12.97M | -13.83M | -18.23M | -20.21M | -19.2M | -17.15M | -18.16M | -47.84M | -30.28M | -26.8M | -31.51M |
Depreciation & Amortization | 456K | 666K | 512K | 586K | 540K | 419K | 392K | 333K | 174K | 363K | 282K | 283K |